⌕
Chemed · CHE · NYSE
Tenet 48 · Mixed
Compare
$546.75−0.49%At closeTenet 48 · Mixed
$546.75−2.70 (−0.49%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Chemed (CHE) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice
50
VALUE
Fairly priced
in line with its peers
62
QUALITY
Decent
elite returns, mid-pack margins
45
HEALTH
Stable
manageable balance sheet
35
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A decent business at a fair price: value 50, quality 62, health 45, growth 35, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
50th pctilein line with its peers
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.5.1%66th pctileTTM through Sep 30, 2026
P/E25.660th pctileTTM through Sep 30, 2026 · as of close, Nov 16, 2026
P/B8.322nd pctileSep 30, 2026 balance sheet
P/FCF24.247th pctileTTM through Sep 30, 2026
EV / EBITDA16.754th pctileTTM through Sep 30, 2026 · as of close, Nov 16, 2026
45th pctilemanageable balance sheet
Current ratio1.119th pctileSep 30, 2026 balance sheet
Quick ratio(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.0.9216th pctileSep 30, 2026 balance sheet
Net debt / EBITDADebt less cash and all investments, including long-term stakes, over EBITDA, as the data vendor builds it0.4×57th pctileTTM through Sep 30, 2026
Interest coverage75.4×95th pctileTTM through Sep 30, 2026
Debt / equity0.2750th pctileSep 30, 2026 balance sheet
62nd pctileelite returns, mid-pack margins
ROIC25%93rd pctileTTM through Sep 30, 2026
ROE29%88th pctileTTM through Sep 30, 2026
Gross margin33.5%16th pctileTTM through Sep 30, 2026
Net margin10.6%72nd pctileTTM through Sep 30, 2026
Income quality (CFO/NI)1.29×27th pctileTTM through Sep 30, 2026
Piotroski F5 / 953rd pctileown record too shortFiscal year to Sep 30, 2026
Altman Z9.884th pctileTTM through Sep 30, 2026
35th pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin11.1%62nd pctileTTM through Sep 30, 2026
the receipts behind the numbers above
Greenblatt earnings yield5.1%EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC25%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage75.4× EBIT ÷ interest expense, ranked within sector peers.
Percentiles computed nightly against 340 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 16, 2026 · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.